Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
|
Apr 2016
|
Anemia
|
myelodysplastic syndromes (MDS)
|
Spontaneous remision of aplastic anemia occurring during a pregnancy
|
Aug 2012
|
Ann Biol Clin (Paris)
|
aplastic anemia
|
Myelodysplastic syndromes: pathophysiology, clinical and biological features
|
Dec 2015
|
Ann Biol Clin (Paris)
|
myelodysplastic syndromes (MDS)
|
Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide
|
May 2014
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol
|
Aug 2016
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
|
Oct 2015
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia
|
Aug 2017
|
Ann Hematol
|
aplastic anemia
|
Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients
|
Jul 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|